Regulation of transforming growth factor-beta1 gene expression and cell proliferation in human hepatocellular carcinoma cells (PLC/PRF/5) by tamoxifen. (Q40942692)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 1999

Language	Label	Description	Also known as
English	Regulation of transforming growth factor-beta1 gene expression and cell proliferation in human hepatocellular carcinoma cells (PLC/PRF/5) by tamoxifen.	scientific article published on July 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402064%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Regulation of transforming growth factor-beta1 gene expression and cell proliferation in human hepatocellular carcinoma cells (PLC/PRF/5) by tamoxifen (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402064%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402064%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

M Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402064%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

G Y Minuk

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402064%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402064%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Translational Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402064%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

134

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402064%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402064%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

90-95

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402064%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Hepatocellular carcinoma. A worldwide problem and the major risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Tamoxifen treatment in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

A phase II trial of tamoxifen in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Selective reversal of vinblastine resistance in multidrug-resistant cell lines by tamoxifen, toremifene and their metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Elevated levels of plasma transforming growth factor-beta in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Positive correlation of plasma transforming growth factor-beta 1 levels with tumor vascularity in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Lowry protein assay containing sodium dodecyl sulfate in microtiter plates for protein determinations on fractions from brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

An improved MTT assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Expression of Transforming Growth Factor-β1 mRNA in Human Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990058-6

7 January 2021

Identifiers

10.1016/S0022-2143(99)90058-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402064%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402064%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40942692&oldid=1962194719"